174 related articles for article (PubMed ID: 10233950)
1. Sequences between the enhancer and promoter in the long terminal repeat affect murine leukemia virus pathogenicity and replication in the thymus.
Yoshimura FK; Wang T; Cankovic M
J Virol; 1999 Jun; 73(6):4890-8. PubMed ID: 10233950
[TBL] [Abstract][Full Text] [Related]
2. Role of the LTR region between the enhancer and promoter in mink cell focus-forming murine leukemia virus pathogenesis.
Yoshimura FK; Wang T
Virology; 2001 Apr; 283(1):121-31. PubMed ID: 11312668
[TBL] [Abstract][Full Text] [Related]
3. Contributions to transcriptional activity and to viral leukemogenicity made by sequences within and downstream of the MCF13 murine leukemia virus enhancer.
Tupper JC; Chen H; Hays EF; Bristol GC; Yoshimura FK
J Virol; 1992 Dec; 66(12):7080-8. PubMed ID: 1331510
[TBL] [Abstract][Full Text] [Related]
4. Identification of a region of a murine leukemia virus long terminal repeat with novel transcriptional regulatory activities.
Chen H; Yoshimura FK
J Virol; 1994 May; 68(5):3308-16. PubMed ID: 8151791
[TBL] [Abstract][Full Text] [Related]
5. Tissue-specific replication of Friend and Moloney murine leukemia viruses in infected mice.
Evans LH; Morrey JD
J Virol; 1987 May; 61(5):1350-7. PubMed ID: 3033265
[TBL] [Abstract][Full Text] [Related]
6. Mapping of functional regions of murine retrovirus long terminal repeat enhancers: enhancer domains interact and are not independent in their contributions to enhancer activity.
Hollon T; Yoshimura FK
J Virol; 1989 Aug; 63(8):3353-61. PubMed ID: 2545910
[TBL] [Abstract][Full Text] [Related]
7. Mink cell focus-forming murine leukemia virus infection induces apoptosis of thymic lymphocytes.
Yoshimura FK; Wang T; Yu F; Kim HR; Turner JR
J Virol; 2000 Sep; 74(17):8119-26. PubMed ID: 10933722
[TBL] [Abstract][Full Text] [Related]
8. Thymocyte-thymic epithelial cell interaction leads to high-level replication of human immunodeficiency virus exclusively in mature CD4(+) CD8(-) CD3(+) thymocytes: a critical role for tumor necrosis factor and interleukin-7.
Chêne L; Nugeyre MT; Guillemard E; Moulian N; Barré-Sinoussi F; Israël N
J Virol; 1999 Sep; 73(9):7533-42. PubMed ID: 10438843
[TBL] [Abstract][Full Text] [Related]
9. A single point mutation in the envelope gene is responsible for replication and XC fusion deficiency of the endogenous ecotropic C3H/He murine leukemia virus and for its repair in culture.
Sithanandam G; Rapp UR
J Virol; 1988 Mar; 62(3):932-43. PubMed ID: 2828688
[TBL] [Abstract][Full Text] [Related]
10. Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo.
Ethelberg S; Lovmand J; Schmidt J; Luz A; Pedersen FS
J Virol; 1997 Oct; 71(10):7273-80. PubMed ID: 9311802
[TBL] [Abstract][Full Text] [Related]
11. A protein-binding site with dyad symmetry in the long terminal repeat of the MCF13 murine leukemia virus that contributes to transcriptional activity in T lymphocytes.
Yoshimura FK; Diem K; Chen H; Tupper J
J Virol; 1993 Apr; 67(4):2298-304. PubMed ID: 8383242
[TBL] [Abstract][Full Text] [Related]
12. Free and integrated recombinant murine leukemia virus DNAs appear in preleukemic thymuses of AKR/J mice.
Herr W; Gilbert W
J Virol; 1984 Apr; 50(1):155-62. PubMed ID: 6321787
[TBL] [Abstract][Full Text] [Related]
13. The feline leukemia virus long terminal repeat contains a potent genetic determinant of T-cell lymphomagenicity.
Pantginis J; Beaty RM; Levy LS; Lenz J
J Virol; 1997 Dec; 71(12):9786-91. PubMed ID: 9371646
[TBL] [Abstract][Full Text] [Related]
14. Replication of enhancer-deficient amphotropic murine leukemia virus in human cells.
Reuss FU; Berdel B; Ploss M; Heber R
Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10898-903. PubMed ID: 11535815
[TBL] [Abstract][Full Text] [Related]
15. Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappaB enhancer element into a GABP binding site.
Verhoef K; Sanders RW; Fontaine V; Kitajima S; Berkhout B
J Virol; 1999 Feb; 73(2):1331-40. PubMed ID: 9882338
[TBL] [Abstract][Full Text] [Related]
16. In vitro studies of the mechanism of leukemogenesis. II. Characterization of endogenous murine leukemia viruses isolated from AKR thymic epithelial reticulum cell lines.
Yanagihara K; Hamada K; Seyama T; Imamura N; Yokoro K
J Virol; 1982 Feb; 41(2):360-6. PubMed ID: 6281454
[TBL] [Abstract][Full Text] [Related]
17. Genetic alterations of RNA leukemia viruses associated with the development of spontaneous thymic leukemia in AKR/J mice.
Thomas CY; Coffin JM
J Virol; 1982 Aug; 43(2):416-26. PubMed ID: 6287025
[TBL] [Abstract][Full Text] [Related]
18. Thymic epithelial genotype influences the production of recombinant leukemogenic retroviruses in mice.
Datta SK; Thomas CY; Nicklas JA; Coffin JM
J Virol; 1983 Jul; 47(1):33-45. PubMed ID: 6306280
[TBL] [Abstract][Full Text] [Related]
19. Differential DNA binding of nuclear proteins to a long terminal repeat region of the MCF13 and Akv murine leukemia viruses.
Yoshimura FK; Tupper J; Diem K
J Virol; 1989 Nov; 63(11):4945-8. PubMed ID: 2552174
[TBL] [Abstract][Full Text] [Related]
20. Analysis of wild-type and mutant SL3-3 murine leukemia virus insertions in the c-myc promoter during lymphomagenesis reveals target site hot spots, virus-dependent patterns, and frequent error-prone gap repair.
Nielsen AA; Sørensen AB; Schmidt J; Pedersen FS
J Virol; 2005 Jan; 79(1):67-78. PubMed ID: 15596802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
